Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but come “too soon,” one analyst said.
Warren Buffett starts downsizing his Bank of America bet — Here’s what could lie behind the move
Warren Buffett surprised many by reducing one of his longest held and largest positions — Bank of America. Here’s what could have driven the sale.
Earnings playbook: Your guide to the busiest week of the season, including Microsoft and Apple
Strap in. The busiest week of the earnings season is upon us.
Ron Insana: How investors ought to prepare their portfolios for November’s elections
Ron Insana recommends investors keep some dry powder regardless of who wins the presidential election.
Activist Trian has a few levers to pull to build shareholder value at Solventum
Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.
These are the biggest shorts on Wall Street today, including this downbeat auto stock
Short interest ticked higher over the past month.
Bill Ackman’s IPO of Pershing Square closed-end fund is postponed, NYSE says
Bill Ackman is postponing the highly scrutinized listing of Pershing Square’s U.S. closed-end fund, according to a notice on the NYSE’s website.
This bank cut the 5.25% yield on its 1-year CD. Where to find compelling rates
Several banks are trimming back yields on savings products well before the Federal Reserve cuts rates.
Nvidia could be on the verge of a massive technical sell-off, chart analyst warns
Nvidia has struggled in July and could have further downside, according to Raymond James.
Disney is among the most oversold stocks on Wall Street. Here are the others
Several companies appear oversold this week and could be due for a rebound after a wild week on Wall Street.